Antiparkinsonian medication masks motor signal progression in de novo patients

Antiparkinsonian medication masks motor signal progression in de novo patients

<p>Patients not yet receiving medication provide insight to drug-naïve early physiology of Parkinson's Disease (PD). Wearable sensors can measure changes in motor features before and after introduction of antiparkinsonian medication. We aimed to identify features of upper limb br...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Brzezicki, MA, Conway, N, Sotirakis, C, FitzGerald, JJ, Antoniades, CA
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Cell Prss 2023

समान संसाधन

Antiparkinsonian medication masks motor signal progression in de novo patients
द्वारा: Maksymilian A. Brzezicki, और अन्य
प्रकाशित: (2023-06-01)

Identification of motor progression in Parkinson's disease using wearable sensors and machine learning
द्वारा: Sotirakis, C, और अन्य
प्रकाशित: (2023)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
द्वारा: Sotirakis, C, और अन्य
प्रकाशित: (2024)

Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
द्वारा: Charalampos Sotirakis, और अन्य
प्रकाशित: (2023-10-01)

Strategy adherence: a specific and rapidly progressive deficit in progressive supranuclear palsy
द्वारा: Brzezicki, MA, और अन्य
प्रकाशित: (2021)

Longitudinal monitoring of progressive supranuclear palsy using body-worn movement sensors
द्वारा: Sotirakis, C, और अन्य
प्रकाशित: (2022)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
द्वारा: Charalampos Sotirakis, और अन्य
प्रकाशित: (2024-12-01)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
द्वारा: Pereira, MF, और अन्य
प्रकाशित: (2022)

Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning
द्वारा: De Vos, M, और अन्य
प्रकाशित: (2020)

Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
द्वारा: Bredemeyer, O, और अन्य
प्रकाशित: (2022)

Amantadine: an antiviral and antiparkinsonian agent
द्वारा: J. Staničová, और अन्य
प्रकाशित: (2001-09-01)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
द्वारा: T. L. Pitcher, और अन्य
प्रकाशित: (2014-01-01)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
द्वारा: Sara Silva, और अन्य
प्रकाशित: (2021-04-01)

Drug utilization study of antiparkinsonian medication in Romania during 25 years
द्वारा: Camelia Bucsa, और अन्य
प्रकाशित: (2025-02-01)

Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study
द्वारा: Su, ZH, और अन्य
प्रकाशित: (2022)

Quantifying motor impairment in movement disorders
द्वारा: FitzGerald, J, और अन्य
प्रकाशित: (2018)

Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling
द्वारा: Gilberto eFisone, और अन्य
प्रकाशित: (2011-07-01)

PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
द्वारा: Natalya Avdeeva, और अन्य
प्रकाशित: (2016-12-01)

In vitro neuroprotective effects of dua-acting antiparkinsonians
द्वारा: Vera Silva, और अन्य
प्रकाशित: (2022-04-01)

Quantifying Motor Impairment in Movement Disorders
द्वारा: James J. FitzGerald, और अन्य
प्रकाशित: (2018-04-01)

Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication
द्वारा: Carsten Buhmann, और अन्य
प्रकाशित: (2004-02-01)

Efficacy of antiparkinsonian therapy in tremor correction according to tremorography
द्वारा: V. A. Bogacheva, और अन्य
प्रकाशित: (2024-04-01)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
द्वारा: Nicola Paccione, और अन्य
प्रकाशित: (2022-12-01)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
द्वारा: Caio M. Massari, और अन्य
प्रकाशित: (2017-10-01)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson’s Disease in Response to Antiparkinsonian Drugs
द्वारा: Soutarou Taguchi, और अन्य
प्रकाशित: (2019-01-01)

Novel cognitive markers for early diagnosis and monitoring of progressive supranuclear palsy
द्वारा: Brzezicki, M, और अन्य
प्रकाशित: (2021)

Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113
द्वारा: O. Yu. Kravtsova, और अन्य
प्रकाशित: (2024-06-01)

Disulfide bridge-targeted metabolome mining unravels an antiparkinsonian peptide
द्वारा: Zhiwu Tong, और अन्य
प्रकाशित: (2024-02-01)

Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models
द्वारा: Carine Coneglian de Farias, और अन्य
प्रकाशित: (2014-12-01)

Antiparkinsonian effect of dicholine succinate on the model of MPTP-induced parkinsonism
द्वारा: A. K. Sariev, और अन्य
प्रकाशित: (2017-02-01)

Eye movements and deep brain stimulation
द्वारा: FitzGerald, J, और अन्य
प्रकाशित: (2016)

Using saccadometry with deep brain stimulation to study normal and pathological brain function
द्वारा: Antoniades, C, और अन्य
प्रकाशित: (2016)

High resolution photon counting CT permits direct visualisation of directional deep brain stimulation lead segments and markers
द्वारा: Manfield, J, और अन्य
प्रकाशित: (2023)

Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures
द्वारा: Vladimir N. Fedorov, और अन्य
प्रकाशित: (2024-12-01)

Objectivization of efficiency of antiparkinsonian drug administration in correction of different types of tremor
द्वारा: D. V. Zakharov, और अन्य
प्रकाशित: (2018-07-01)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
द्वारा: Soutarou Taguchi, और अन्य
प्रकाशित: (2021-01-01)

A novel machine learning based framework for developing composite digital biomarkers of disease progression
द्वारा: Zhai, S, और अन्य
प्रकाशित: (2025)

Development of marked striatal hand with antiparkinsonian medication withdrawal during traditional (Ayurvedic) medicine treatment for Parkinson's disease
द्वारा: Lim, Shen-Yang, और अन्य
प्रकाशित: (2010)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
द्वारा: Marko Bogdanovic, और अन्य
प्रकाशित: (2022-04-01)

Impact of Duration of Parkinsonism and Antiparkinsonian Drugs on Coagulation Parameters in Patients with Parkinson’s Disease
द्वारा: Varun Kodam, और अन्य
प्रकाशित: (2024-10-01)